IP Library Patent Application 15651469
Patent Application
App. No. 15/651,469

ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/651,469
Abstract

The present invention relates to the use of tissue non-specific alkaline phosphatase (TNAP) as a marker for identifying and/or isolating adult multipotential cells. The present invention also relates to cell populations enriched by methods of the present invention and therapeutic uses of these cells.

Claims (20)

1 - 45 . (canceled)

46 . An enriched population of TNAP + adult multipotential cells, wherein at least 4% of the total cell population are TNAP + , STRO-1 + multipotential cells capable of being cultured in vitro to produce adipocytes, osteocytes and chondrocytes, wherein the TNAP + marker is a TNAP + marker which binds the STRO-3 antibody produced by the hybridoma cell line deposited under ATCC Accession Number PTA-5582.

47 . An enriched population according to claim 46 , wherein at least 10% of the total cell population are TNAP + , STRO-1 + multipotential cells capable of being cultured in vitro to produce adipocytes, osteocytes and chondrocytes.

48 . An enriched population according to claim 46 , wherein at least 20% of the total cell population are TNAP + , STRO-1 + multipotential cells capable of being cultured in vitro to produce adipocytes, osteocytes and chondrocytes.

49 . An enriched population according to claim 46 , wherein the STRO-1 + cells are STRO-1 bright .

50 . An enriched population according to claim 47 , wherein the STRO-1 + cells are STRO-1 bright .

51 . An enriched population according to claim 48 , wherein the STRO-1 + cells are STRO-1 bright .

52 . A method of generating a committed cell population of a specific tissue type, the method comprising culturing a population of adult multipotential cells according to claim 46 in the presence of one or more stimulatory factors; and subjecting said cultured population to conditions biasing differentiation of the adult muitipotential cells to the specific tissue type.

53 . A method of generating a committed cell population of a specific tissue type, the method comprising culturing a population of adult multipotential cells according to claim 47 in the presence of one or more stimulatory factors; and subjecting said cultured population to conditions biasing differentiation of the adult muitipotential cells to the specific tissue type.

54 . A method of generating a committed cell population of a specific tissue type, the method comprising culturing a population of adult multipotential cells according to claim 48 in the presence of one or more stimulatory factors; and subjecting said cultured population to conditions biasing differentiation of the adult muitipotential cells to the specific tissue type.

55 . A method of generating a committed cell population of a specific tissue type, the method comprising culturing a population of adult multipotential cells according to claim 49 in the presence of one or more stimulatory factors; and subjecting said cultured population to conditions biasing differentiation of the adult muitipotential cells to the specific tissue type.

56 . A composition comprising the enriched population of adult multipotential cells according to claim 46 .

57 . A composition comprising the enriched population of adult multipotential cells according to claim 47 .

58 . A composition comprising the enriched population of adult multipotential cells according to claim 48 .

59 . A composition comprising the enriched population of adult multipotential cells according to claim 49 .

60 . A method for generating or repairing tissue in a subject in need thereof, the method comprising administering to the subject the enriched cell population according to claim 46 so as to generate or repair the tissue.

61 . A method for generating or repairing tissue in a subject in need thereof, the method comprising administering to the subject the enriched cell population according to claim 47 so as to generate or repair the tissue.

62 . A method for generating or repairing tissue in a subject in need thereof, the method comprising administering to the subject the enriched cell population according to claim 48 so as to generate or repair the tissue.

63 . A method for generating or repairing tissue in a subject in need thereof, the method comprising administering to the subject the enriched cell population according to claim 49 so as to generate or repair the tissue.

64 . A method for generating or repairing tissue in a subject in need thereof, the method comprising administering to the subject the composition according to claim 56 so as to generate or repair the tissue.

Assignments (4)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT AT REEL/FRAME NO. 45759/0682 Recorded Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2017
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM; SIMMONS, PAUL JOHN
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 043028/0153 →
CHANGE OF NAME Recorded Jul 18, 2017
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 043218/0368 →